Physician profile
Benjamin J Mathews
NPI 1770725392
$395.25
in general payments reported to CMS, 2019-2025
9 companies · $80.62 in 2025
The $80.62 reported for 2025 was less than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $315 · 2025: $80.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $126.69 | 2024-2025 | Zerbaxa, Dificid, Prevymis |
| Janssen Pharmaceuticals, INC | $57.04 | 2024 | Xarelto |
| Alexion Pharmaceuticals, INC. | $56.29 | 2024 | Ultomiris |
| La Jolla Pharmaceutical Company | $41.63 | 2024-2025 | Giapreza |
| Astellas Pharma US INC | $32.39 | 2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $22.97 | 2024 | |
| Abbvie INC. | $21.88 | 2024 | |
| Tetraphase Pharmaceuticals, INC. | $21.52 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $14.84 | 2024 | Airsupra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Mathews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.